Going to test human embryonic stem cell therapy

California-based biotech company Geron has been approved by the US Food and Drug Administration to conduct trials using embryonic stem cells to treat paralyzed patients with spinal injuries. This is the first time in the world, embryonic stem cells have been clinically tested on humans.

Geron will conduct stem cell testing on humans in the next few months.Photo: Daily Mail

Scientists hope that injecting stem cells extracted from embryos into the spinal column of voluntary patients will stimulate damaged nerve cells to grow back and even allow patients to recover their sensation and move. Dr. Richard Fessler of Northwestern University, who will preside over Geron's experiment, thinks that if stem cell therapy is effective on people it will bring hope to thousands of patients with spinal cord injury. heavy every year.

Adult stem cells, which can only produce certain types of tissue, have been tested on humans but the results are quite limited. Researchers hope the use of embryonic stem cells, capable of transforming into any cell type in the body, will revolutionize medicine, from the creation of organs for cases. Transplant to support new drug testing process. Stem cell therapy is also useful for patients with memory impairment (Alzheimer's disease) and multiple sclerosis.

Source: Daily Mail